The event will provide opportunities to network with the people who are shaping pricing strategies across Europe
Redwood Shores, CA and London, UK (PRWEB) March 22, 2012
Model N, the leader in Revenue Management, will be sponsoring the Second-Annual European Pricing Platform (EPP) Life Sciences Pricing and Profit Optimization Forum in Montreux on May 23 and 24.
EPP is the leading knowledge community for pricing decision makers in Europe.
This high-profile, two-day event will bring together leaders from finance, sales, marketing, and pricing to address current operational and strategic challenges in the European Life Sciences market.
Day One topics explore the challenges faced by the industry, including how to adapt a commercial strategy for a new era and share best practice for addressing reference pricing and parallel trade. A range of expert speakers including representatives from Baxter Healthcare, Amgen Commercial International Commercial Operations (ICO), and Boston Scientific (EMEA) will share their most effective strategies and success stories.
Day Two topics will include European tender management, rebate and incentives, and compliance, and a detailed examination of best practice concerning optimization of net price and margins. Day two speakers include representatives from Boston Scientific EMEA, Novartis, and Global.
“This event brings together the Life Sciences community in Europe, providing a great opportunity for our partners, customers, and the industry at large to debate and address the challenges ahead,” says Niels Skov, Managing Director, Model N Europe. “Model N is pleased, once more, to partner with EPP to host the 2nd Annual EPP Life Sciences Pricing and Profit Optimization forum.”
Founded in 2004, the European Pricing Platform has become the leading knowledge exchange for European pricing decision makers, revenue managers, and CxO’s, dedicated to developing and sharing pricing knowledge, best practices, and resources both live and online.
The event will provide opportunities to network with leaders in the sector; the people who are shaping pricing strategies across Europe. Amongst those present will be key policy-makers and stakeholders from Novartis, Global, Baxter Healthcare, Amgen ICO, Boston Scientific, UCB, and EPP.
“Model N has proven to be a highly valuable partner that offers our audience best practices expertise in the industry,” said Pol Vanaerde, EPP President. “We are excited to continue and further strengthen our fruitful partnership and look forward to stimulating discussions and interactions on European Life Sciences pricing in Montreux.”
About Model N
With over £100b in annual revenues across 50 countries managed in our Revenue Management systems, Model N leverages its deep Industry expertise and best practices, highly configurable applications and comprehensive services to support Life Sciences and High Tech organizations on premise or in the cloud. Whether you are an emerging business or a global leader, Model N results in revenue. http://www.modeln.com
About The European Pricing Platform (EPP)
EPP is a ‘Not-for-Profit’ knowledge exchange focused on supporting business management, pricing, and profit optimization professionals, and CxO-level executives in Europe across a variety of industries and sectors. Our target is to update the pricing and profit optimization know-how of business managers. Our mission is to be the premier pricing expertise community for international decision makers in a wide range of industries. The interactive sharing, collecting, and development of pricing and profit optimization knowledge are the key elements of our platform. http://www.pricingplatform.eu.
Model N is a mark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.